GSK Updates Phase I/II Therapeutic HSV Vaccine Trial
Ticker: GLAXF · Form: 6-K · Filed: Sep 11, 2024 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Sep 11, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: clinical-trial-update, vaccine, pharmaceuticals
Related Tickers: GSK
TL;DR
GSK dropped an update on its HSV vaccine trial, check the 6-K for deets.
AI Summary
GSK plc announced on September 11, 2024, an update on its Phase I/II therapeutic herpes simplex virus (HSV) vaccine trial. The company, trading under LSE/NYSE: GSK, provided this information in a Form 6-K filing.
Why It Matters
This update provides insight into the progress of GSK's vaccine development for HSV, a common viral infection, which could impact future treatment options.
Risk Assessment
Risk Level: low — The filing is a routine update on a clinical trial and does not contain significant financial or strategic changes that would pose a high risk.
Key Players & Entities
- GSK plc (company) — Registrant and subject of the update
- September 11, 2024 (date) — Date of the announcement and filing
- herpes simplex virus (HSV) (medical_condition) — The target of the therapeutic vaccine trial
- LSE/NYSE: GSK (stock_ticker) — Trading symbols for GSK plc
FAQ
What is the specific update provided by GSK regarding the Phase I/II therapeutic HSV vaccine trial?
The filing states that GSK plc "announced that it has comp" which is an incomplete sentence, indicating the full update details are not present in the provided text snippet.
When was this update issued by GSK plc?
The update was issued on 11 September 2024, from London UK.
What form was used for this SEC filing?
This filing was made on Form 6-K, a Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934.
What is GSK plc's principal executive office address?
GSK plc's principal executive office is located at 980 Great West Road, Brentford, Middlesex, TW8 9GS.
Has GSK plc previously operated under different names?
Yes, GSK plc was formerly known as GSK PLC, with a date of name change on 20220516, and prior to that, it was known as GLAXOSMITHKLINE PLC, with a date of name change on 20010105.
Filing Stats: 626 words · 3 min read · ~2 pages · Grade level 13.2 · Accepted 2024-09-11 06:37:50
Filing Documents
- a6638d.htm (6-K) — 32KB
- 0001654954-24-011711.txt ( ) — 33KB
SIGNATURES
SIGNATURES   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.   GSK plc   (Registrant)     Date: September 11, 2024         By:/s/ VICTORIA WHYTE --------------------------       Victoria Whyte   Authorised Signatory for and on   behalf of GSK plc